Ameritas Investment Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Ameritas Investment Partners’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14,933	Closed	-$395K	–	3188
2019 Q1	$395K	Buy	14,933 +1,000	+7%	+$23.7K	0.02%	794
2018 Q4	$272K	Hold	13,933	–	–	0.01%	848
2018 Q3	$273K	Hold	13,933	–	–	0.01%	925
2018 Q2	$231K	Hold	13,933	–	–	0.01%	998
2018 Q1	$198K	Hold	13,933	–	–	0.01%	1076
2017 Q4	$203K	Hold	13,933	–	–	0.01%	1078
2017 Q3	$190K	Hold	13,933	–	–	0.01%	1088
2017 Q2	$165K	Hold	13,933	–	–	0.01%	1158
2017 Q1	$206K	Hold	13,933	–	–	0.01%	1039
2016 Q4	$225K	Hold	13,933	–	–	0.01%	982
2016 Q3	$253K	Buy	13,933 +1,361	+11%	+$26.6K	0.01%	922
2016 Q2	$207K	Buy	+12,572	New	+$203K	0.01%	939

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameritas Investment Partners's HZNP Position: Q2 2019 in Review

Ameritas Investment Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2019, closing a stake of 14,933 shares — an estimated $395K sold.

Ameritas Investment Partners first reported a position in HZNP in Q2 2016 and held it in 12 quarters. The position peaked at $395K in Q1 2019. 272 funds tracked by Wall St. Rank hold HZNP as of Q2 2019.

Ameritas Investment Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2019 after selling out during the quarter.
Ameritas Investment Partners sold 14,933 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2019, an estimated $395K.
Ameritas Investment Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2016 and held it in 12 quarters.
Ameritas Investment Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $395K in Q1 2019.
272 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2019.

Based on Ameritas Investment Partners's 13F filing for Q2 2019, filed 14 Aug 2019.